Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Oncology
  4. Acidic and hypoxic tumor microenvironment regulation by ­CaO2‑loaded polydopamine nanoparticles

Acidic and hypoxic tumor microenvironment regulation by ­CaO2‑loaded polydopamine nanoparticles

Journal of Nanobiotechnology, 2022 · DOI: 10.1186/s12951-022-01752-8 · Published: December 28, 2022

OncologyPharmacologyBiomedical

Simple Explanation

The tumor microenvironment, characterized by hypoxia and high lactic acid accumulation, promotes tumor development. This study introduces ­CaO2-loaded nanoparticles to simultaneously regulate both acidic and hypoxic conditions. ­CaO2-loaded mesoporous polydopamine nanoparticles modified with sodium hyaluronate (­CaO2@mPDA-SH) accumulate in the tumor site, consuming lactic acid and generating oxygen in the acidic microenvironment, thus remodeling the tumor microenvironment. By alleviating hypoxia, the nanoparticles further reduce lactate production by down-regulating HIF-1α and glycolysis-associated enzymes, efficiently repressing tumor progression through immune activation, anti-metastasis, and anti-angiogenesis.

Study Duration
15-day observation period
Participants
BALB/c mice (female, 5–6  weeks old)
Evidence Level
Not specified

Key Findings

  • 1
    CaO2@mPDA-SH nanoparticles can dually regulate tumor hypoxia and lactic acid metabolism.
  • 2
    The nanoparticles promote immune activation, inhibit tumor metastasis, and reduce angiogenesis, thereby repressing tumor progression.
  • 3
    The treatment decreases lactate and hypoxia levels, significantly inhibiting tumor growth.

Research Summary

The study developed ­CaO2@mPDA-SH nanoparticles that can regulate the tumor microenvironment by consuming lactic acid and alleviating hypoxia. The nanoparticles promote immune responses, inhibit angiogenesis and metastasis, and reduce lactic acid production by down-regulating HIF-1α and glycolysis-associated enzymes. This strategy offers a new therapeutic approach for tumor treatment by targeting both the acidic and hypoxic aspects of the tumor microenvironment.

Practical Implications

Novel Therapeutic Strategy

The CaO2@mPDA-SH nanoparticles offer a new method for tumor treatment by simultaneously targeting the acidic and hypoxic microenvironment.

Potential for Immunotherapy

By promoting immune activation and reducing immunosuppressive factors, the nanoparticles enhance the effectiveness of immunotherapy.

Anti-Metastatic Applications

The lactate-depleting action of the nanoparticles can reduce tumor metastasis and angiogenesis, improving patient outcomes.

Study Limitations

  • 1
    The study primarily focuses on in vitro and in vivo experiments using murine models, necessitating further validation in human clinical trials.
  • 2
    The long-term effects and potential toxicity of CaO2@mPDA-SH nanoparticles require more extensive investigation.
  • 3
    The precise mechanisms of immune activation and the specific signaling pathways involved need further elucidation.

Your Feedback

Was this summary helpful?

Back to Oncology